Unknown

Dataset Information

0

R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats.


ABSTRACT: (±)-Modafinil (MOD) is used clinically for the treatment of sleep disorders and has been investigated as a potential medication for the treatment of psychostimulant addiction. However, the therapeutic efficacy of (±)-MOD for addiction is inconclusive. Herein we used animal models of self-administration and in vivo microdialysis to study the pharmacological actions of R-modafinil (R-MOD) and S-modafinil (S-MOD) on nicotine-taking and nicotine-seeking behavior, and mechanisms underlying such actions. We found that R-MOD is more potent and effective than S-MOD in attenuating nicotine self-administration in Long-Evans rats. As Long-Evans rats did not show a robust reinstatement response to nicotine, we used alcohol-preferring rats (P-rats) that display much higher reinstatement responses to nicotine than Long-Evans rats. We found that R-MOD significantly inhibited intravenous nicotine self-administration, nicotine-induced reinstatement, and nicotine-associated cue-induced drug-seeking behavior in P-rats. R-MOD alone neither sustained self-administration in P-rats previously self-administering nicotine nor reinstated extinguished nicotine-seeking behavior. The in vivo brain microdialysis assays demonstrated that R-MOD alone produced a slow-onset moderate increase in extracellular DA. Pretreatment with R-MOD dose-dependently blocked nicotine-induced dopamine (DA) release in the nucleus accumbens (NAc) in both naive and nicotine self-administrating rats, suggesting a DA-dependent mechanism underlying mitigation of nicotine's effects. In conclusion, the present findings support further investigation of R-MOD for treatment of nicotine dependence in humans.

SUBMITTER: Wang XF 

PROVIDER: S-EPMC4915260 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring rats.

Wang Xiao-Fei XF   Bi Guo-Hua GH   He Yi Y   Yang Hong-Ju HJ   Gao Jun-Tao JT   Okunola-Bakare Oluyomi M OM   Slack Rachel D RD   Gardner Eliot L EL   Xi Zheng-Xiong ZX   Newman Amy Hauck AH  

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20150123 7


(±)-Modafinil (MOD) is used clinically for the treatment of sleep disorders and has been investigated as a potential medication for the treatment of psychostimulant addiction. However, the therapeutic efficacy of (±)-MOD for addiction is inconclusive. Herein we used animal models of self-administration and in vivo microdialysis to study the pharmacological actions of R-modafinil (R-MOD) and S-modafinil (S-MOD) on nicotine-taking and nicotine-seeking behavior, and mechanisms underlying such actio  ...[more]

Similar Datasets

| S-EPMC3572467 | biostudies-literature
| S-EPMC6093676 | biostudies-literature
2009-12-31 | GSE15415 | GEO
| S-EPMC4455882 | biostudies-literature
2009-12-30 | E-GEOD-15415 | biostudies-arrayexpress
| S-EPMC5152912 | biostudies-literature